Abbott Laboratories (ABT)

Basic

  • Market Cap

    $177.18B

  • EV

    $186.05B

  • Shares Out

    1,736.06M

  • Revenue

    $39.96B

  • Employees

    115,000

Margins

  • Gross

    55.17%

  • EBITDA

    24.7%

  • Operating

    16.6%

  • Pre-Tax

    15.49%

  • Net

    12.92%

  • FCF

    11.24%

Returns (5Yr Avg)

  • ROA

    5.59%

  • ROE

    14.61%

  • ROCE

    10.73%

  • ROIC

    10.13%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $116.25

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $22.95

  • Earnings (Dil)

    $2.94

  • FCF

    $2.57

  • Book Value

    $21.59

Growth (CAGR)

  • Rev 3Yr

    7.44%

  • Rev 5Yr

    5.62%

  • Rev 10Yr

    7.02%

  • Dil EPS 3Yr

    16.03%

  • Dil EPS 5Yr

    45.07%

  • Dil EPS 10Yr

    16.94%

  • Rev Fwd 2Yr

    -2.26%

  • EBITDA Fwd 2Yr

    -7.14%

  • EPS Fwd 2Yr

    -6.96%

  • EPS LT Growth Est

    8%

Dividends

  • Yield

    —

  • Payout

    69.07%

  • DPS

    $2.04

  • DPS Growth 3Yr

    12.31%

  • DPS Growth 5Yr

    12.74%

  • DPS Growth 10Yr

    13.8%

  • DPS Growth Fwd 2Yr

    5.82%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

30,578.0

31,904.0

34,608.0

43,075.0

43,653.0

39,959.0

Total Revenues % Chg.

11.6%

4.3%

8.5%

24.5%

1.3%

-11.3%

Cost of Goods Sold, Total

12,696.0

13,231.0

14,855.0

18,066.0

19,074.0

17,913.0

Gross Profit

17,882.0

18,673.0

19,753.0

25,009.0

24,579.0

22,046.0

Selling General & Admin Expenses, Total

9,568.0

9,540.0

9,591.0

11,006.0

10,842.0

10,681.0

R&D Expenses

2,298.0

2,440.0

2,365.0

2,738.0

2,888.0

2,750.0

Amortization of Goodwill and Intangible Assets

2,178.0

1,936.0

2,132.0

2,047.0

2,013.0

1,981.0

Other Operating Expenses, Total

14,044.0

13,916.0

14,088.0

15,791.0

15,743.0

15,412.0

Operating Income

3,838.0

4,757.0

5,665.0

9,218.0

8,836.0

6,634.0

Interest Expense, Total

-826.0

-670.0

-546.0

-533.0

-558.0

-632.0

Interest And Investment Income

105.0

94.0

46.0

43.0

183.0

384.0

Net Interest Expenses

-721.0

-576.0

-500.0

-490.0

-375.0

-248.0

Currency Exchange Gains (Loss)

-28.0

-7.0

8.0

-1.0

-2.0

-3.0

Other Non Operating Income (Expenses)

-21.0

-34.0

13.0

7.0

-40.0

21.0

EBT, Excl. Unusual Items

3,068.0

4,140.0

5,186.0

8,734.0

8,419.0

6,404.0

Restructuring Charges

-28.0

—

—

-509.0

-68.0

-170.0

Merger & Related Restructuring Charges

—

—

—

—

—

—

Gain (Loss) On Sale Of Investments

—

—

-115.0

—

-45.0

-45.0

Gain (Loss) On Sale Of Assets

—

—

—

—

—

—

Asset Writedown

—

—

-203.0

-14.0

—

—

Legal Settlements

—

—

100.0

—

—

—

Other Unusual Items

-167.0

-63.0

—

—

—

—

EBT, Incl. Unusual Items

2,873.0

4,077.0

4,968.0

8,211.0

8,306.0

6,189.0

Income Tax Expense

539.0

390.0

497.0

1,140.0

1,373.0

1,027.0

Earnings From Continuing Operations

2,334.0

3,687.0

4,471.0

7,071.0

6,933.0

5,162.0

Earnings Of Discontinued Operations

34.0

—

24.0

—

—

—

Net Income

2,368.0

3,687.0

4,495.0

7,071.0

6,933.0

5,162.0

Preferred Dividend and Other Adjustments

15.0

21.0

22.0

29.0

28.0

20.0

Net Income to Common Incl Extra Items

2,353.0

3,666.0

4,473.0

7,042.0

6,905.0

5,142.0

Net Income to Common Excl. Extra Items

2,319.0

3,666.0

4,449.0

7,042.0

6,905.0

5,142.0

Total Shares Outstanding

1,755.6

1,762.5

1,771.2

1,764.1

1,737.8

1,736.1

Weighted Avg. Shares Outstanding

1,758.0

1,768.0

1,773.0

1,775.0

1,753.0

1,741.0

Weighted Avg. Shares Outstanding Dil

1,770.0

1,781.0

1,786.0

1,789.0

1,764.0

1,750.7

EPS

1.3

2.1

2.5

4.0

3.9

3.0

EPS Diluted

1.3

2.1

2.5

3.9

3.9

2.9

EBITDA

7,116.0

7,771.0

8,992.0

12,756.0

12,103.0

9,871.0